Austin Mark John 4
4 · Perspective Therapeutics, Inc. · Filed Jul 19, 2024
Insider Transaction Report
Form 4
Austin Mark John
Controller/Prin Fin&Acct Offic
Transactions
- Award
Stock Option (right to buy)
2024-07-17+34,500→ 34,500 totalExercise: $11.96Exp: 2034-07-17→ Common Stock (34,500 underlying)
Footnotes (1)
- [F1]Option vests over four years with 1/48th of the shares subject to such option vesting and becoming exercisable in substantially equal monthly installments on the monthly anniversary after the Grant Date (07/17/2024), subject to a continued service relationship.